Table 1 |
||
|
Characteristics of Participants |
||
|
Autism Group |
Neurotypical Group |
|
|
|
||
|
Total Participants |
55 |
44 |
|
|
||
|
Male |
49 (89%) |
39 (89%) |
|
|
||
|
Female |
6 (11%) |
5(11%) |
|
|
||
|
Age (years) |
10.0 +/- 3.1 |
11.0 +/- 3.1 |
|
|
||
|
Diagnosis |
85% autism, 4% PDD/NOS, 11% Asperger's |
In good mental and physical health |
|
|
||
|
Medications |
55% no medications 29% psycho-pharmaceuticals - primarily risperidone and clonidine; 9% on CNS stimulants (primarily Concerta); 4% on anti-convulsants 5% on GI medications; 7% on asthma/allergy medicine; 2% on insulin |
89% no medications; 9% on anti-inflammatories (asthma/allergies); 2% on anti-incontinence medication |
|
|
||
|
Special Diets |
84% on regular diet; 3 gluten-free, casein-free diet; 1 gluten-free; 3 reduced dairy/gluten; 2 low sugar |
1 child on dairy-free diet |
|
|
||
|
Nutritional Supplements |
1 on fish oil; 2 on melatonin |
none |
|
|
||
|
PDD-BI (modified autism composite) |
-63 +/- 54 |
n/a |
|
|
||
|
ATEC |
64 +/- 25 |
n/a |
|
|
||
|
SAS |
4.9 +/- 2.4 |
n/a |
|
|
||
|
Adams et al. Nutrition & Metabolism 2011 8:34 doi:10.1186/1743-7075-8-34 |
||